首页 正文

A patent review of hepatitis B virus core protein allosteric modulators (2019-present)

{{output}}
Introduction: The hepatitis B virus (HBV) core protein is a significant therapeutic target due to its essential role in HBV replication. Over the past five years, numerous structurally unique CpAMs have been patented. However, no... ...